SE:ORX Stock Latest News
Company AnnouncementsOrexo Sets Terms for SEK 253 Million Rights Issue4h ago
Company AnnouncementsOrexo Wins FDA Review of High‑Dose Naloxone Nasal Powder IZIPRY4d ago
Company AnnouncementsOrexo AB Earnings Call: Pipeline Progress Amid Strain1w ago
Company AnnouncementsOrexo Deepens R&D-Driven Transformation Amid Losses and Capital Raise1w ago
Pre-EarningsORXOF Upcoming Earnings Report: What to Expect?1w ago
Company AnnouncementsOrexo to Present Q3 2026 Interim Results in Live Investor Call2w agoCompany AnnouncementsOrexo launches 250 MSEK rights issue to fund pipeline and strengthen finances3w ago
Company AnnouncementsOrexo convenes EGM to approve rights issue and capital authorizations3w ago
Company AnnouncementsOrexo Resubmits High-Dose Opioid Overdose Rescue Drug IZIPRY for FDA Review1M ago
Company AnnouncementsOrexo Wins FDA Green Light to Advance Needle‑Free Anaphylaxis Treatment OX6401M ago
Company AnnouncementsOrexo Wins BARDA Funding Boost to Extend OX390 Overdose Rescue Development1M ago
Company AnnouncementsOrexo CFO Fredrik Järrsten to Step Down as Company Streamlines Operations2M ago
Company AnnouncementsOrexo Advances Nasal Rescue Pipeline as Losses Deepen in Q2 20263M ago- Company AnnouncementsOrexo strengthens partnership strategy with new business development chief4M ago
Company AnnouncementsOrexo posts positive in‑vivo data for nasal overdose reversal candidate OX3905M ago- Company AnnouncementsOrexo AGM Backs Board, Expands Capital Flexibility and Incentive Plans5M ago
Company AnnouncementsOrexo Deepens R&D Push as Losses Widen and Bond Redeemed Early6M ago
Company AnnouncementsOrexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan7M ago